USANA Health Sciences Inc. (USNA) Major Shareholder Sells $1,346,700.00 in Stock
USANA Health Sciences Inc. (NYSE:USNA) major shareholder Global Ltd Gull sold 10,000 shares of the business’s stock in a transaction dated Wednesday, September 14th. The shares were sold at an average price of $134.67, for a total value of $1,346,700.00. Following the completion of the sale, the insider now owns 6,329,110 shares in the company, valued at $852,341,243.70. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Global Ltd Gull also recently made the following trade(s):
- On Wednesday, August 10th, Global Ltd Gull sold 10,000 shares of USANA Health Sciences stock. The shares were sold at an average price of $135.08, for a total value of $1,350,800.00.
- On Wednesday, July 13th, Global Ltd Gull sold 10,000 shares of USANA Health Sciences stock. The shares were sold at an average price of $118.96, for a total value of $1,189,600.00.
Shares of USANA Health Sciences Inc. (NYSE:USNA) opened at 134.13 on Wednesday. USANA Health Sciences Inc. has a 12 month low of $92.00 and a 12 month high of $144.46. The company has a market capitalization of $1.61 billion, a PE ratio of 17.68 and a beta of 1.16. The stock’s 50 day moving average price is $136.13 and its 200 day moving average price is $124.60.
USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, July 26th. The company reported $2.07 EPS for the quarter, beating the consensus estimate of $2.05 by $0.02. USANA Health Sciences had a return on equity of 34.15% and a net margin of 10.07%. The company had revenue of $258.50 million for the quarter, compared to analysts’ expectations of $256.66 million. During the same period last year, the firm posted $1.92 earnings per share. USANA Health Sciences’s revenue was up 10.8% compared to the same quarter last year. On average, analysts forecast that USANA Health Sciences Inc. will post $8.10 EPS for the current year.
Several large investors have recently added to or reduced their stakes in USNA. Royal Bank of Canada boosted its stake in USANA Health Sciences by 25.2% in the second quarter. Royal Bank of Canada now owns 3,080 shares of the company’s stock valued at $344,000 after buying an additional 620 shares during the period. Calvert Investment Management Inc. acquired a new stake in USANA Health Sciences during the second quarter valued at approximately $789,000. Legal & General Group Plc boosted its stake in USANA Health Sciences by 30.9% in the second quarter. Legal & General Group Plc now owns 1,696 shares of the company’s stock valued at $186,000 after buying an additional 400 shares during the period. Cubist Systematic Strategies LLC acquired a new stake in USANA Health Sciences during the second quarter valued at approximately $305,000. Finally, Cantab Capital Partners LLP boosted its stake in USANA Health Sciences by 39.1% in the second quarter. Cantab Capital Partners LLP now owns 4,046 shares of the company’s stock valued at $451,000 after buying an additional 1,138 shares during the period. 41.86% of the stock is currently owned by institutional investors.
A number of equities research analysts recently issued reports on the company. Zacks Investment Research upgraded USANA Health Sciences from a “hold” rating to a “strong-buy” rating and set a $158.00 price objective on the stock in a research note on Saturday, July 30th. DA Davidson boosted their price objective on USANA Health Sciences from $135.00 to $150.00 and gave the company a “neutral” rating in a research note on Thursday, July 28th. Two investment analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $149.11.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. It operates as a direct selling company in approximately two geographic regions: Americas and Europe, and Asia Pacific, which includes approximately three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.